B3GNT3 has been demonstrated to be an oncogene in several cancers (e.g. lung cancer, pancreatic cancer, and breast cancer), and participates in lymphocyte trafficking and migration [13, 15, 16]. This evidence concerns the gene B3GNT3 and cancer.